Long-term outcome in patients injected for CTS in 2007 - Version 1.0
Research type
Research Study
Full title
A cohort study of the long term clinical course of patients initially treated for carpal tunnel syndrome by local corticosteroid injection during 2007
IRAS ID
169925
Contact name
Jeremy Bland
Contact email
Sponsor organisation
East Kent Hospitals University NHS Foundation Trust
Duration of Study in the UK
0 years, 2 months, 29 days
Research summary
Carpal tunnel syndrome is the most common peripheral nerve problem in the UK. It is a condition in which one of the major nerves to the hand, the median nerve, becomes compressed in a confined space at the wrist. It causes symptoms of tingling, numbness and pain in the hand which are typically worse at night but tend to spread into the daytime with increasing severity. In advanced cases there is weakness of the thumb muscles and there can be permanent loss of sensation. Local corticosteroid injection is effective in the short term but little is known about the long term outcomes of injection. The only other proven treatments are night splinting, and surgery to open the carpal tunnel and relieve the pressure on the nerve.
We will identify from the records of the Canterbury carpal tunnel clinic all patients referred for treatment during 2007 who had confirmed CTS on nerve conduction studies and who either opted for injection as an initial treatment or who initially selected surgery but then changed their minds and had injection(s).
The study will last for two months. Within this timeframe participants will have been screened for eligibility, sent postal packs (PIS, ICF, Initial query letter and Boston Carpal Tunnel Questionnaire) to complete, phoned and then followed up if necessary. Follow up is only necessary if we need to contact participants in order to gain better clarity regarding their responses.REC name
London - Bloomsbury Research Ethics Committee
REC reference
15/LO/0343
Date of REC Opinion
10 Mar 2015
REC opinion
Favourable Opinion